Monday, October 12, 2026

EUR/CHF Jumps By 1% In The Last 5 Sessions

ViaNews Editorial Team

November 4, 2023

EUR/CHF Jumps By 1% In The Last 5 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.86% for the last 5 sessions. At 22:06 EST on Friday, 3 November, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 2.315% up from its 52-week low and 4.576% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a positive 0.24%, a negative 0.05%, and a positive 0.26%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.44% (last week), 0.30% (last month), and 0.26% (last quarter), respectively.

News about

  • Usd/jpy price analysis: remains above 151.00 post retreating from a yearly high. According to FXStreet on Wednesday, 1 November, "Furthermore, the 14-day Relative Strength Index (RSI) above the 50 level indicates a favorable market sentiment, supporting the notion of bullish momentum for the USD/JPY pair.", "On the upside, the USD/JPY could face resistance near the highs marked in October 2022 at 151.94, which is lined up with a 152.00 psychological level."
  • Usd/jpy steady near 151.00 as markets chew on fed rate hold. According to FXStreet on Wednesday, 1 November, "The USD/JPY is holding steady near the 151.00 handle as the Federal Reserve (Fed) holds rates at 5.25-5.5%, as markets broadly expected, but a lack of significant changes in the Fed's rate statement leaves investors unsure of an additional rate hike in December to close out the year.", "The USD/JPY continues to catch bids from the 21-day Exponential Moving Average (EMA) currently lifting into 150.00, and medium-term support is baking in from the 50-day Simple Moving Average (SMA) near 148.50."
  • Usd/jpy tumbles from daily highs as US bond yields plunge, awaiting fed’s decision. According to FXStreet on Wednesday, 1 November, "With the Fed's decision right around the corner, the USD/JPY remains offered due to the latest economic releases. ", "Even though the bank tweaked the Yield Curve Control (YCC), the USD/JPY printed a new year-to-date (YTD) high of 151.72, though authorities and the BoJ remain on hold of intervening in the Forex markets. "
  • According to DailyForex on Wednesday, 1 November, "The USD/JPY currency pair rose strongly yesterday to trade well above the big round number at ¥151 not far from the 30-year high price made last year, but then fell back after Japan's currency diplomat Kanda said he would not rule out any steps to respond to disorderly FX moves and that he remains on standby for intervention "if needed". "
  • According to FXStreet on Wednesday, 1 November, "Japanese authorities expressed concerns about "one-sided moves," but USD/JPY remained firm above 150.00, trading near multi-decade highs. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com